Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia

Clinical Science

Volumn 90, Issue 5, 1996, Pages 369-377

  Liaudet, Lucas ^a   Feihl, François ^a   Rosselet, Anne ^a   Markert, Michèle ^a   Hurni, Jean Marc ^a   Perret, Claude ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Endotoxin; L canavanine; Mouse; Nitric oxide; Nitric oxide synthase inhibitors; Rat

Indexed keywords

ARGININE; CANAVANINE; LACTIC ACID; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PH; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; ENDOTOXEMIA; ENZYME INHIBITION; HEART FAILURE; HEART INDEX; HYPOVOLEMIA; INTRAVENOUS DRUG ADMINISTRATION; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0029936671     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900369     Document Type: Article

References (33)

1. Beal AL, Cerra FB. Multiple organ failure in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226-33.
2. Thijs LG, Schneider AJ, Groeneveld ABJ. The haemodynamics of septic shock. Intens Care Med 1990; 16: S182-6.
3. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
4. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259: H1038-43.
5. Kilbourn RG, Jubran A, Gross SS, et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-8.
6. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-9.
7. Robertson FM, Offner PJ, Ciceri DP, Bechker WK, Pruitt BA. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149-56.
8. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48-57.
9. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142-8.
10. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338: 1555-7.
11. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995; 114: 1666-72.
12. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91: 12472-6.
13. Umans JG, Samsel RW. L-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur J Pharmacol 1992; 210: 343-6.
14. Isoyama T, Sato T, Tanaka J, Shatney CH. Measurement of cardiac output in small animals by aortic thermodilution. J Surg Res 1982; 33: 170-6.
15. Yamamoto J, Trippodo NC, Ishise S, Frohlich ED. Total vascular pressure-volume relationship in the conscious rat. Am J Physiol 1980; 238: H823-8.
16. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 1995; 3: 2-32.
17. Teale DM, Atkinson AM. L-canavanine restores blood pressure in a rat model of endotoxic shock. Eur J Pharmacol 1994; 271: 87-92.
18. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96: 418-24.
19. Iyengar R, Stuehr DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 1987; 84: 6369-73.
20. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108: 786-92.
21. Biber B, Schaefer CF, Smolik MJ, et al. Improved techniques for cardiovascular monitoring in rats as applied during endotoxemia. Am J Physiol 1988; 254: H181-6.
22. Rackow E, Astiz M, Kim Y, Weil M. Monophosphoryl lipid A blocks the hemodynamic effects of lethal endotoxemia. J Lab Clin Med 1989; 113: 112-17.
23. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993; 265: H176-82.
24. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (Washington DC) 1992; 257: 387-9.
25. Keller R, Jones J, Kim K, et al. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide. Shock 1995; 4: 338-44.
26. Vallance P, Palmer RMJ, Moncada S. The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits. Br J Pharmacol 1992; 106: 459-63.
27. Spain DA, Wilson MA, Garison RN. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994; 116: 322-31.
28. ω-Amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176: 1175-52.
29. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262: H611-15.
30. Mulder MF, Van Lambalgen AA, Huisman E, Visser JJ, Van Den Bos GC, Thijs LG. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 1994; 266: H1558-64.
31. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Shapira AHV. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett 1994; 345: 50-4.
32. Geng YJ, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992; 71: 1268-76.
33. Tiao G, Rafferty J, Ogle C, Fisher J E, Hasselgren P O. Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 1994; 116: 332-8.